For research use only. Not for therapeutic Use.
Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research[1].
| Catalog Number | I044857 |
| CAS Number | 86541-79-9 |
| Synonyms | (3S,5R,6S,8S,10S,13R,14S,16S,17R)-17-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6,16-triol |
| Molecular Formula | C30H50O5 |
| Purity | ≥95% |
| InChI | InChI=1S/C30H50O5/c1-25(2)21(33)10-12-27(5)17-9-13-28(6)24(30(8)14-11-22(35-30)26(3,4)34)20(32)16-29(28,7)18(17)15-19(31)23(25)27/h9,18-24,31-34H,10-16H2,1-8H3/t18-,19+,20+,21+,22+,23+,24+,27-,28-,29+,30-/m1/s1 |
| InChIKey | KNESISUQBYQIIU-LOIFQKOGSA-N |
| SMILES | CC1(C(CCC2(C1C(CC3C2=CCC4(C3(CC(C4C5(CCC(O5)C(C)(C)O)C)O)C)C)O)C)O)C |
| Reference | [1]. Bilge Debeleç-Bütüner, et al. Cycloartane-type sapogenol derivatives inhibit NF-κB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids. 2018 Jul;135:9-20. |
